5-(4-Formylphenyl)pyrimidine - CAS 198084-12-7

Name: 5-(4-Formylphenyl)pyrimidine
Brand: BOC Sciences
Rating: 5 (1 reviews)

Catalog:	BB015311
Product Name:	5-(4-Formylphenyl)pyrimidine
CAS:	198084-12-7
Synonyms:	4-pyrimidin-5-ylbenzaldehyde

Technical Data

Safety and Hazards

Patents

Computed Properties

IUPAC Name:	4-pyrimidin-5-ylbenzaldehyde
Description:	5-(4-Formylphenyl)pyrimidine (CAS# 198084-12-7) is a useful reactant and reagent in organic reactions such as the synthesis of 1,2-difluorination of alkenes, and β-Cyanoacrylamides.
Molecular Weight:	184.19
Molecular Formula:	C11H8N2O
Canonical SMILES:	C1=CC(=CC=C1C=O)C2=CN=CN=C2
InChI:	InChI=1S/C11H8N2O/c14-7-9-1-3-10(4-2-9)11-5-12-8-13-6-11/h1-8H
InChI Key:	BXNXTOLXLPQMHS-UHFFFAOYSA-N
Boiling Point:	369.1 °C at 760 mmHg
Density:	1.205 g/cm³
MDL:	MFCD02684108
LogP:	1.95610

Related Products

Online Inquiry

Name:

* Phone:

* Service & Products of Interested:

Project Description:

* Quantity:

* Email:

* Verification Code:

Customer Support

If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?

Submit Requirement

Customer Centered

Global Delivery

Warehouses in multiple cities to ensure fast delivery

Quality Assurance

Strict process parameter control to ensure product quality

Large Stock

> 20,000 building blocks and intermediates from stock

Process Scale-up

Process scale-up from lab to industrial scale

Flexible Batch Size

Flexible batch size for diverse industrial demands

Related Functional Groups

Carbonyl Compounds

[1006443-01-1]C9H6N4O4
1-(5-Nitropyridin-2-yl)-1H-pyrazole-3-carboxylic acid
[4313-03-5]C7H10O
2,4-Heptadienal
[151585-93-2]C7H6FNO
2-Amino-6-fluorobenzaldehyde
[5000-66-8]C8H6BrClO
2-Bromo-2'-chloroacetophenone
[99-60-5]C7H4ClNO4
2-Chloro-4-nitrobenzoic acid
[113366-46-4]C7H9NO2S
2-Ethyl-4-methyl-1,3-thiazole-5-carboxylic acid

GHS Hazard Statement:	H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Precautionary Statement:	P264, P270, P280, P301+P312, P305+P351+P338, P330, P337+P313, and P501
Signal Word:	Warning

Publication Number	Title	Priority Date
KR-102114389-B1	Novel sodium channel inhibitor compound, preparation method thereof, and pharmaceutical composition for prevention or treatment of sodium channel related diseases containing the same as an active ingredient	20180502
KR-20190126525-A	Novel sodium channel inhibitor compound, preparation method thereof, and pharmaceutical composition for prevention or treatment of sodium channel related diseases containing the same as an active ingredient	20180502
KR-101859074-B1	Novel glycine amide compound or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of diseases induced by activation of sodium channel containing the same as an active ingredient	20160128
KR-20170090547-A	Novel glycine amide compound or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of diseases induced by activation of sodium channel containing the same as an active ingredient	20160128
EP-3349581-A1	Hepatitis b core protein modulators	20150915

Complexity:	182
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	1
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	184.063662883
Formal Charge:	0
Heavy Atom Count:	14
Hydrogen Bond Acceptor Count:	3
Hydrogen Bond Donor Count:	0
Isotope Atom Count:	0
Monoisotopic Mass:	184.063662883
Rotatable Bond Count:	2
Topological Polar Surface Area:	42.8 Å²
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0
XLogP3:	1.3